Titlebook: Vaccine Design; The Subunit and Adju Michael F. Powell,Mark J. Newman Book 1995 Plenum Press, New York 1995 antigen.calcium.protein.vaccine

implicate

書目名稱Vaccine Design影響因子(影響力)




書目名稱Vaccine Design影響因子(影響力)學(xué)科排名




書目名稱Vaccine Design網(wǎng)絡(luò)公開度




書目名稱Vaccine Design網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Vaccine Design被引頻次




書目名稱Vaccine Design被引頻次學(xué)科排名




書目名稱Vaccine Design年度引用




書目名稱Vaccine Design年度引用學(xué)科排名




書目名稱Vaccine Design讀者反饋




書目名稱Vaccine Design讀者反饋學(xué)科排名

CHAFE

A Compendium of Vaccine Adjuvants and Excipients,cited significant local and systemic adverse reactions that precluded their use in human vaccine formulations. Alum adjuvant, first described in 1926, remains the only immunologic adjuvant used in human vaccines licensed in the United States.

閹割

帶來墨水

Little

curriculum

偽造

obnoxious

fructose

Liposome Design and Vaccine Development,deficiency virus (HIV-1) (Koff and Hoth, 1988; Wintsh ., 1991), pertussis toxoid (Burnette, 1992; Nencioni ., 1990), and malaria (Gordon, 1993; Fries ., 1992; Richards ., 1988). A common thread in the composition of many of these subunit vaccines is the inclusion of an adjuvant.

BRACE

Laboratory Empiricism, Clinical Design, and Social Value,full disease prevention potential of vaccines has yet to be realized. Smallpox has been eradicated by vaccine. Polio may soon be eradicated by vaccine. Measles, tetanus, diphtheria, and pertussis have been markedly reduced. But, considering the potential for the control or elimination of diseases with vaccine, we have only scratched the surface.